Genes and Nutrition is a prominent open access journal published by BMC in the United Kingdom, dedicated to advancing knowledge at the intersection of nutrition, genetics, and human health. With the aim of making cutting-edge research available to a global audience, the journal has been a vital platform for sharing discoveries since its inception in 2007, and it continues to thrive with a convergence period extending to 2024. Recognized for its high-quality contributions, Genes and Nutrition is rated in the Q2 category within both Endocrinology, Diabetes, and Metabolism and Genetics as of 2023, reflecting its esteemed position in these fields (Scopus Ranks leaderboard places it at #72/244 and #109/347, respectively). This journal is an invaluable resource for researchers, professionals, and students alike, fostering collaboration and innovation in the understanding of how genetic factors influence nutrition and health outcomes. Accessible to all since 2016, it encourages dialogue and discovery, positioning itself as a leader in genetic and nutritional science.

Genetic Testing and Molecular Biomarkers, an esteemed journal published by MARY ANN LIEBERT, INC, serves as a pivotal platform for advancing the field of genetic research and its applications in medicine. Focused on the innovative intersections of genetics and biomarker discovery, this journal has consistently contributed meaningful insights since its inception in 2009, with its scope evolving through 2024. With an ISSN of 1945-0265 and an E-ISSN of 1945-0257, it offers both traditional and open access options to cater to a broad audience of researchers, professionals, and students. Despite its current classification in the Q4 and Q3 quartiles for Genetics (clinical) and Medicine (miscellaneous) respectively, the journal remains committed to publishing high-quality, peer-reviewed articles that push the boundaries of knowledge in the field. As the landscape of genomic medicine continues to expand, Genetic Testing and Molecular Biomarkers is positioned as a crucial resource for disseminating cutting-edge discoveries and fostering interdisciplinary collaboration.

The Annual Review of Genetics is a premier academic journal dedicated to advancing the field of genetics through critical, comprehensive reviews that synthesize current research and highlight future directions. Published by Annual Reviews, this esteemed journal boasts an impressive impact factor, ranking in the Q1 category for Genetics, and holds a distinguished position as 14th out of 347 journals in the Scopus ranking for Genetics, placing it in the 96th percentile among its peers. With its convergence of knowledge from 1970 to 2023, the journal serves as an essential resource for researchers, professionals, and students alike, facilitating a deeper understanding of genetic principles and their applications. Although the journal is not open access, it remains a vital platform for disseminating high-quality, peer-reviewed content that shapes the conversation in genetics, making it a must-read for those seeking to stay at the forefront of this dynamic field.

GENETICS AND MOLECULAR RESEARCH is a distinguished academic journal published by FUNPEC-EDITORA, focusing on the rapidly evolving fields of genetics and molecular biology. Since its inception in 2002, the journal has provided a platform for high-quality research and advancements that contribute to our understanding of genetic mechanisms and molecular interactions. With an impressive convergence period extending through 2024, this open-access journal presents vital insights while maintaining accessibility for researchers, professionals, and students alike. Though currently positioned in the Q4 quartile in Genetics, Medicine (Miscellaneous), and Molecular Biology as per the latest 2023 rankings, its persistent publication efforts aim to elevate its influence within the academic community. Researchers are invited to explore groundbreaking studies that may inform future developments in these critical scientific domains.

The Journal of Gene Medicine, published by Wiley, stands as a pivotal resource in the field of gene therapy and molecular medicine, with a rich history of dissemination of impactful research since its inception in 1998. With an ISSN of 1099-498X and an E-ISSN of 1521-2254, this esteemed journal plays a crucial role in advancing our understanding of genetics and drug discovery, reflected in its impressive 2023 Scopus rankings where it holds a Q2 classification in Drug Discovery and Q3 in several genetics-related categories. The journal aims to facilitate the exchange of high-quality research findings that bridge the gap between laboratory and clinical applications, making it an essential platform for researchers, academics, and healthcare professionals committed to the forefront of genetic innovation. Although it does not currently offer open access options, its reputation for rigorous peer review ensures that all published work meets the highest academic standards, providing a reliable reference for scientific inquiry in the United States and beyond. As the field rapidly evolves, the Journal of Gene Medicine remains at the helm, guiding future discoveries with its influential publications and comprehensive insights.

Human Genomics, published by BMC, is a leading open-access journal dedicated to advancing the field of genomics and its applications in health and disease. Since its inception in 2003, the journal has provided a vital platform for researchers to disseminate groundbreaking findings related to genetic research, contributing significantly to areas such as Drug Discovery, Genetics, Molecular Biology, and Molecular Medicine, as reflected in its Q1 and Q2 quartile rankings throughout 2023. With an ISSN of 1473-9542 and an E-ISSN of 1479-7364, Human Genomics not only delivers high-quality, peer-reviewed research but also ensures accessibility to a broader audience, empowering professionals, students, and academics to stay at the forefront of genomic science. Through its rigorous editorial standards and impactful publications, the journal fosters a collaborative environment for innovative research across the globe from its base in the United Kingdom. By promoting open access since its launch, Human Genomics continues to enhance the visibility and impact of genetic studies, making it an essential resource for anyone involved in the rapidly evolving field of human genomics.

Annual Review of Genomics and Human Genetics, published by ANNUAL REVIEWS, represents a pivotal platform in the field of Genetics and Molecular Biology. With an impressive impact factor reflecting its high citation rate and scholarly influence, this journal is renowned for its authoritative reviews that synthesize current research across genomics and human genetics. Highlighting its Q1 category rankings in both Genetics and Clinical Genetics, as well as its ranking within the top tiers of Biochemistry and Genetics, the journal stands out as a leading resource for researchers, professionals, and students eager to stay abreast of groundbreaking developments in these rapidly evolving fields. While not currently an open access journal, its rigorous peer-review process ensures the highest standards of scientific integrity. Researchers can access comprehensive reviews that delve into both fundamental genetics concepts and cutting-edge discoveries, making it an essential resource for advancing understanding in human genetics and its applications.

Frontiers in Genetics is a premier academic journal dedicated to advancing the field of genetics through high-quality, peer-reviewed research. Published by FRONTIERS MEDIA SA in Switzerland since 2010, this Open Access journal provides a platform for researchers and practitioners to disseminate innovative findings across various subfields, including clinical genetics and molecular medicine. With a notable emphasis on interdisciplinary approaches, the journal holds a strong position in the academic landscape, achieving Q2 rankings in key categories such as Genetics and Molecular Medicine in 2023. Not only does Frontiers in Genetics contribute to the scholarly dialogue by publishing impactful studies, but it also promotes accessibility to vital research, ensuring that knowledge is available to a global audience. This journal is a vital resource for researchers, professionals, and students looking to stay at the forefront of genetic discoveries and their applications, reflective of its engagement with contemporary challenges in genetics and healthcare.

MUTAGENESIS, published by Oxford University Press, is a leading journal in the fields of genetics, toxicology, and health, dedicated to advancing our understanding of mutagenic processes and their implications for human health. With an ISSN of 0267-8357 and an E-ISSN of 1464-3804, this journal has been at the forefront of mutagenesis research since its inception in 1986 and will continue to publish cutting-edge studies until 2024. Holding an impressive position in the academic community, MUTAGENESIS is ranked Q2 in Genetics, Q2 in Clinical Genetics, Q2 in Health, Toxicology, and Mutagenesis, and Q1 in Toxicology, reflecting its commitment to high-quality scholarly work. The journal enjoys a robust global readership, with significant rankings in various Scopus categories, including top positions in Environmental Science and Clinical Genetics, ensuring that it remains a vital resource for researchers, professionals, and students alike. While access to its articles is not completely open, MUTAGENESIS provides valuable insights that fuel innovative research and drive forward the understanding of genetic risks and toxicological assessments.

Cytology and Genetics is an esteemed academic journal published by PLEIADES PUBLISHING INC, dedicated to advancing research within the fields of cytology, cellular biology, and genetics. Since its inception in 1978, the journal has served as a platform for disseminating innovative findings and methodologies pertinent to contemporary biological sciences. With an ISSN of 0095-4527 and an E-ISSN of 1934-9440, Cytology and Genetics offers critical insights that significantly contribute to the current understanding of genetic mechanisms and cellular processes. Despite its present positioning in the Q4 quartile across multiple categories, including Agricultural and Biological Sciences and Cell Biology, the journal remains a crucial resource for emerging researchers seeking to explore complex genetic and cytogenetic landscapes. With an emphasis on empirical studies and comprehensive reviews, the journal aims to bridge gaps in knowledge and foster collaboration among scholars in the United States and beyond. As a vital tool for students, professionals, and researchers, Cytology and Genetics invites contributions that reflect the future of genetics and cytological science.